4//SEC Filing
Denbaars Steven 4
Accession 0001493152-25-017607
CIK 0001938569other
Filed
Oct 8, 8:00 PM ET
Accepted
Oct 9, 4:21 PM ET
Size
7.8 KB
Accession
0001493152-25-017607
Insider Transaction Report
Form 4
Denbaars Steven
Director
Transactions
- Sale
Warrants
2025-09-29$1.20/sh+125,000$150,000→ 125,000 totalExercise: $1.50From: 2025-09-29→ Common Stock (125,000 underlying) - Other
Common Stock
2025-09-29+1,625,000→ 1,750,000 total
Footnotes (1)
- [F1]Per the terms of an Agreement and Plan of Merger, dated September 29, 2025, Palomino Acquisition Co., a subsidiary of Issuer, merged into Rhino Subsidiary Inc. (f/k/a Palomino Laboratories Inc., "Pre-Merger Palomino"). Mr. DenBaars, as a shareholder of Pre-Merger Palomino, received 1,500,000 shares of common stock, par value $0.0001 per share, of Issuer ("Common Stock") in exchange for his Pre-Merger Palomino shares. On September 29, 2025, Issuer closed a private placement offering and, during which, Mr. DenBaars converted his SAFEs into 125,000 Units at a price of $1.20 per Unit. Each Unit consists of one share of the Common Stock and one warrant to purchase one share of Common Stock at an exercise price of $1.50. The warrants expire on the first anniversary of the date the Common Stock is admitted for trading or listed on an Approved Market (as defined in warrant agreement).
Documents
Issuer
Palomino Laboratories Inc.
CIK 0001938569
Entity typeother
Related Parties
1- filerCIK 0001700533
Filing Metadata
- Form type
- 4
- Filed
- Oct 8, 8:00 PM ET
- Accepted
- Oct 9, 4:21 PM ET
- Size
- 7.8 KB